Japan stock market week to Oct 27, 2008

3 November 2008

Tokyo share prices plunged in the week ended October 27. The Nikkei 225 tumbled 20.5% to close at 7,162.90, the lowest in 26 years since October 7, 1982, renewing the post bubble low, while the Topix index dropped 19.5%. The market opened higher but accelerated the downswing afterwards because investors were worried that the US economic downturn could cause a slowing of world economies for longer than expected. The yen's rise against the US dollar, euro and other currencies caused both international and domestic players to become cautious about earnings prospects of leading Japanese companies reliant on exports. The market did not receive encouragement from a report about the framework of the Japanese government's emergency measures to stabilize financial markets through purchases of bank-held equities. The pharmaceutical index fell 12.9%, but still outperforming the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight